Tenon Medical Statistics
Total Valuation
Tenon Medical has a market cap or net worth of $10.47 million. The enterprise value is $5.12 million.
Important Dates
The last earnings date was Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Tenon Medical has 7.59 million shares outstanding. The number of shares has increased by 965.55% in one year.
| Current Share Class | 7.59M |
| Shares Outstanding | 7.59M |
| Shares Change (YoY) | +965.55% |
| Shares Change (QoQ) | +111.04% |
| Owned by Insiders (%) | 2.09% |
| Owned by Institutions (%) | 3.86% |
| Float | 7.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.16 |
| Forward PS | 3.32 |
| PB Ratio | 4.28 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.86, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.86 |
| Quick Ratio | 3.36 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -335.48% and return on invested capital (ROIC) is -192.38%.
| Return on Equity (ROE) | -335.48% |
| Return on Assets (ROA) | -94.35% |
| Return on Invested Capital (ROIC) | -192.38% |
| Return on Capital Employed (ROCE) | -151.12% |
| Revenue Per Employee | $109,148 |
| Profits Per Employee | -$468,741 |
| Employee Count | 27 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 2.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.26% in the last 52 weeks. The beta is 1.24, so Tenon Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -71.26% |
| 50-Day Moving Average | 1.09 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 54.74 |
| Average Volume (20 Days) | 13,607,079 |
Short Selling Information
The latest short interest is 67,065, so 0.88% of the outstanding shares have been sold short.
| Short Interest | 67,065 |
| Short Previous Month | 33,991 |
| Short % of Shares Out | 0.88% |
| Short % of Float | 0.95% |
| Short Ratio (days to cover) | 0.37 |
Income Statement
In the last 12 months, Tenon Medical had revenue of $2.95 million and -$12.66 million in losses. Loss per share was -$3.32.
| Revenue | 2.95M |
| Gross Profit | 1.34M |
| Operating Income | -12.92M |
| Pretax Income | -14.33M |
| Net Income | -12.66M |
| EBITDA | -12.61M |
| EBIT | -12.92M |
| Loss Per Share | -$3.32 |
Full Income StatementBalance Sheet
The company has $7.85 million in cash and $290,000 in debt, giving a net cash position of $7.56 million or $1.00 per share.
| Cash & Cash Equivalents | 7.85M |
| Total Debt | 290,000 |
| Net Cash | 7.56M |
| Net Cash Per Share | $1.00 |
| Equity (Book Value) | 6.71M |
| Book Value Per Share | 0.39 |
| Working Capital | 7.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.82 million and capital expenditures -$259,000, giving a free cash flow of -$10.08 million.
| Operating Cash Flow | -9.82M |
| Capital Expenditures | -259,000 |
| Free Cash Flow | -10.08M |
| FCF Per Share | -$1.33 |
Full Cash Flow StatementMargins
| Gross Margin | 45.44% |
| Operating Margin | -438.48% |
| Pretax Margin | -429.45% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Tenon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -965.55% |
| Shareholder Yield | -965.55% |
| Earnings Yield | -99.85% |
| FCF Yield | -79.49% |
Analyst Forecast
The average price target for Tenon Medical is $11.67, which is 745.65% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.67 |
| Price Target Difference | 745.65% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 61.90% |
| EPS Growth Forecast (5Y) | -66.02% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 6, 2024. It was a reverse split with a ratio of 1:8.
| Last Split Date | Sep 6, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |